Iodide

Iodide

SCHEMBL22345583

C[C@@H](NC(=O)c1c[n+](C)nc2ccccc12)C(=O)O.I

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.43
EGLN1 Q9GZT9 2/20 0.43
FTO Q9C0B1 1/20 0.43
TACR3 P29371 6/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL22345356 1.00 BBOX1 (0.43) BBOX1EGLN1FTOTACR3SMN1; SMN2
SCHEMBL22345593 0.99 BBOX1 (0.44) BBOX1EGLN1FTOTACR3SMN1; SMN2
SCHEMBL22345591 0.99 BBOX1 (0.44) BBOX1EGLN1FTOTACR3SMN1; SMN2
Iodide SCHEMBL22345354 0.97 BBOX1 (0.43) BBOX1EGLN1FTOTACR3SMN1; SMN2
Trifluoroacetic Acid SCHEMBL28621807 0.90 BBOX1 (0.41) BBOX1EGLN1FTOTACR3SMN1; SMN2
Trifluoroacetic Acid SCHEMBL29564265 0.90 BBOX1 (0.41) BBOX1EGLN1FTOTACR3SMN1; SMN2
Trifluoroacetic Acid SCHEMBL28621808 0.90 BBOX1 (0.41) BBOX1EGLN1FTOTACR3SMN1; SMN2
Iodide SCHEMBL28632522 0.81 ALDH1A1 (0.42) TACR3KMT2AMEN1KDM4EALDH1A1
Iodide SCHEMBL28632523 0.81 ALDH1A1 (0.42) TACR3KMT2AMEN1KDM4EALDH1A1
Iodide SCHEMBL29564118 0.81 ALDH1A1 (0.42) TACR3KMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 EP disclosed
CN-113423694-A Cinnolinium compounds for use in a method for controlling unwanted plant growth 先正达农作物保护股份公司 2021-09-21 CN disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 BBOX1 28/4885EGLN1 300/4885FTO 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.